4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/04 (2006.01) A61K 31/506 (2006.01) A61K 31/5377 (2006.01) C07D 401/14 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01) C12Q 1/48 (2006.01)

Patent

CA 2592723

The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts thereof. The present invention seeks to provide further substituted heteroaryl-substituted pyrimidine derivatives. More specifically, the invention relates to compounds that have broad therapeutic applications in the treatment of a number of different diseases and/or that are capable of inhibiting one or more protein kinases.

La présente invention concerne des composés de formule (I) ou des sels pharmaceutiquement acceptables de ces composés. La présente invention vise à obtenir des dérivés de pyrimidine à substitution hétéroaryle soumis à une nouvelle substitution. Plus particulièrement, elle concerne des composés présentant de vastes applications thérapeutiques dans le traitement d'une pluralité de maladies différentes et/ou permettant d'inhiber une ou plusieurs protéines kinases.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1436063

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.